Assessment of psychiatric and neurological conditions

• US 20020081745A1
• Filed: 10/15/2001
• Published: 06/27/2002
• Est. Priority Date: 04/14/1999
• Status: Abandoned Application

• Current Assignee: Alezander Iain Munro Glen, Marion Ann Ross
• Original Assignee: Alezander Iain Munro Glen, Marion Ann Ross
• Inventors: Ross, Marion Ann, Glen, Alezander Iain Munro
• Application Number:
  US09/977,475
• Publication Number:
  US 20020081745A1
• Time in Patent Office: Days
• US Class Current: 436/141
• CPC Class Codes: A61B 5/083 Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
• CPC Class Codes: G01N 33/497 of gaseous biological material, e.g. breath
• CPC Class Codes: Y10T 436/214 Acyclic [e.g., methane, octane, isoparaffin, etc.]

Abstract

A method of assessing a psychiatric or neurological condition such as schizophrenia comprises measuring the presence and optionally the amount of butane (and optionally ethane) in the expired breath of the subject. In certain preferred embodiments the variation in the levels of butane is used as an indicator of the presence and optionally the severity of the condition.

Claims

1. A method for the assessment of psychiatric or neurological conditions selected from the group consisting of schizophrenia, bipolar disorder, depression, dementia, Huntingdon'"'"'s chorea, Down'"'"'s syndrome, Alzheimer'"'"'s disease, dyspraxia, stroke, head injury and autistic spectrum disorder, the method comprising determining the presence and/or amount of butane in the expired breath of the patient.

2. A method as claimed in claim 1, comprising the additional step of determining the presence and/or amount of ethane in the expired breath of the patient.

3. A method as claimed in claim 1, wherein the amount of butane is measured and correlated to the severity of the condition in a quantitative manner.

4. A method as claimed in claim 1, wherein the butane in expired breath is thermally desorbed onto a matrix before it'"'"'s presence or amount is determined.

5. A method as claimed in claim 1, wherein the butane is separated from the expired breath by chromatography.

6. A method as claimed in claim 1, wherein the presence or amount of butane determined by mass spectroscopy.

7. A method as claimed in claim 1, wherein the expired breath to be assayed in the method is captured in a breath capture device, and thereafter desorbed onto an absorbent matrix.

8. A method as claimed in claim 1, wherein the butane is analysed by gas chromatography and mass spectrometry.

9. A method as claimed in claim 1, wherein the presence or amount of butane in the expired breath is determined by flame ionisation detection.

10. A method as claimed in claim 1, wherein the presence or amount of butane is determined by analysis selected from the group consisting of infra-red chromatography, fourier transformed infra-red spectroscopy, laser spectroscopy, nuclear magnetic spectroscopy, differential thermal analysis and differential scanning calorimtery.

11. A method as claimed in claim 1, wherein the presence or amount of butane in the expired breath is determined by an electronic device.

12. A method as claimed in claim 1, wherein the butane concentration in expired breath of the patient is measured on several occasions and the variation between the butane levels on each said occasion is determined, and wherein the variation is used as an indicator of the presence of the psychiatric or neurological condition.

13. A method as claimed in claim 12, wherein the variation in the butane levels is used as an indicator of the severity of the psychiatric or neurological condition.